Tag - medicine-4

 
 

MEDICINE 4

Japan Times
WORLD / Science & Health
Oct 28, 2020
Some COVID-19 survivors have antibodies that attack the body, not the virus
Some survivors of COVID-19 carry worrying signs that their immune system has turned on the body, reminiscent of potentially debilitating diseases like lupus and rheumatoid arthritis, a new study has found.
Japan Times
COMMENTARY / Japan
Oct 27, 2020
COVID-19 tests are the real pandemic moneymakers
Renewed outbreaks highlight the need for a better approach to containing the virus, and broad surveillance testing offers a way forward that's easy on the economy.
Japan Times
WORLD / Science & Health
Oct 27, 2020
Oxford COVID-19 vaccine prompts immune response in adults, AstraZeneca says
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among older people, British drug maker AstraZeneca PLC said on Monday.
Japan Times
WORLD / Science & Health
Oct 27, 2020
U.K. study finds evidence of COVID-19 antibody immunity waning over time
Antibodies against the novel coronavirus declined rapidly in the British population during the summer, a study found on Tuesday, suggesting protection after infection may not be long lasting and raising the prospect of waning immunity in the community.
Japan Times
COMMENTARY / World
Oct 26, 2020
COVID-19 explodes the myth that women ‘opt’ out of the workforce
While time away from work is often portrayed as a choice for women, the evidence shows that it's usually a choice reluctantly made.
Japan Times
ASIA PACIFIC / Science & Health
Oct 24, 2020
China defends giving experimental vaccines to thousands
The COVID-19 shot was first give to frontline workers, but has now been rolled out to employees of state-owned companies.
Japan Times
WORLD
Oct 23, 2020
Europe faces dearth of medical staff as new wave tests virus readiness
'Public authorities haven't learned the lessons from the first wave,” said Benoit Labenne, a general practitioner in the Paris suburbs.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
COMMENTARY / World
Oct 21, 2020
Herd immunity, reinfection and the Great Barrington Declaration
COVID-19 selectively kills elderly people, and such people are scarce in countries in Asia and Africa where deaths per million are under 100 in many places.
Japan Times
WORLD / FOCUS
Oct 19, 2020
Getting vaccine doubters to roll up their sleeves won’t be easy
Fading trust in governments, political interference and the dash to create a shot in record time are sowing doubts.
Japan Times
WORLD / Science & Health
Oct 17, 2020
WHO coronavirus vaccine drive bedeviled by familiar question: Who pays if things go wrong?
Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in the battle to beat COVID-19.
Japan Times
BUSINESS / Companies
Oct 16, 2020
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Japan Times
COMMENTARY / World
Oct 14, 2020
New Zealand gives U.S. a lesson in pandemic democracy
The U.S., a nation founded on the principle that all people are created equal and endowed with inalienable rights, would do well to heed the example given by New Zealand.
Japan Times
WORLD / Science & Health
Oct 13, 2020
China looks to give vaccines still being tested to students
Two shots being developed by CNBG which are still in the final, third phase of testing have been authorized for emergency use in the country.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?